All Pharma News
Vividion, Roche Publish Landmark Paper on Covalent WRN Inhibitor

Vividion, Roche Publish Landmark Paper on Covalent WRN Inhibitor
BUSINESSWIRE
25 Apr 2024
Share Share
Vividion starts Phase I trial in advanced solid with oral STAT3 inhibitor

Vividion starts Phase I trial in advanced solid with oral STAT3 inhibitor
PRESS RELEASE
06 Feb 2024
Share Share
Vividion Therapeutics starts Phase I clinical trial with oral STAT3 inhibitor

Vividion Therapeutics starts Phase I clinical trial with oral STAT3 inhibitor
BUSINESSWIRE
06 Feb 2024
Share Share
Vividion Recognized as a San Diego area ‘Top Workplaces 2023’ Award Winner

Vividion Recognized as a San Diego area ‘Top Workplaces 2023’ Award Winner
BUSINESSWIRE
21 Nov 2023
Share Share
Vividion Therapeutics initiates Phase I clinical trial with KEAP1 activator in advanced solid tumors

Vividion Therapeutics initiates Phase I clinical trial with KEAP1 activator in advanced solid tumors
PRESS RELEASE
18 Sep 2023
Share Share
Vividion Therapeutics Names Shawn Rose as Chief Development Officer

Vividion Therapeutics Names Shawn Rose as Chief Development Officer
BUSINESSWIRE
07 Sep 2023
Share Share
Vividion Therapeutics Promotes Matt Patricelli to Chief Scientific Officer

Vividion Therapeutics Promotes Matt Patricelli to Chief Scientific Officer
BUSINESSWIRE
23 Mar 2023
Share Share
Vividion 2.0? Ben Cravatt and Scripps team form a new chemoproteomics biotech

Vividion 2.0? Ben Cravatt and Scripps team form a new chemoproteomics biotech
ENDPTS
04 Jan 2023
Share Share
Bayer`s Vividion Bets up to $930M for Tavros Oncology Partnership

Bayer`s Vividion Bets up to $930M for Tavros Oncology Partnership
Tristan Manalac BIOSPACE
13 Oct 2022
Share Share
An RA-backed startup `ATACs` a novel challenge

An RA-backed startup `ATACs` a novel challenge
Kyle Blankenship ENDPTS
18 Nov 2021
Share Share